Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Þorvarður R. Hálfdánarson

ResearcherPublications, citations & collaboration network

Þorvarður R. Hálfdánarson is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 478 works, 14,969 citations, an h-index of 51 and an i10-index of 159.

478
Works
14,969
Citations
51
h-index
159
i10-index

How has Þorvarður R. Hálfdánarson's publication output changed over time?

ScholarIQpublication output · 2006–2025

Output grew0% over the shown period — from 1 works in 2006 to 1 in 2025.

1
2
1
2
3
1
1
1
20062008201720182019202020212025

What are the most-cited papers on Þorvarður R. Hálfdánarson?

ScholarIQmost cited works
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera, Sanjay Shete, Chih–Yuan Hsu, Aakash Desai, Gilberto Lopes, Petros Grivas, Corrie Painter, Solange Peters, Michael A Thompson, Ziad Bakouny, Gerald Batist, Tanios Bekaii‐Saab, Mehmet Asım Bilen, Nathaniel Bouganim, Mateo Bover Larroya, Daniel Castellano, Salvatore A. Del Prete, Deborah B. Doroshow, Pamela Egan, Arielle Elkrief, Dimitrios Farmakiotis, Daniel Flora, Matthew D. Galsky, Michael Glover, Elizabeth A. Griffiths, Anthony P. Gulati, Shilpa Gupta, Navid Hafez, Þorvarður R. Hálfdánarson, Jessica E. Hawley, Emily Hsu, Anup Kasi, Ali Raza Khaki, Christopher A. Lemmon, Colleen Lewis, Barbara Logan, Tyler Masters, Rana R. McKay, Ruben A. Mesa, Alicia K. Morgans, Mary F. Mulcahy, Orestis A. Panagiotou, Prakash Peddi, Nathan A. Pennell, Kerry L. Reynolds, L Rosen, Rachel Rosovsky, Mary Salazar, Andrew Schmidt, Sumit Shah, Justin Shaya, John A. Steinharter, Keith Stockerl‐Goldstein, Suki Subbiah, Donald C. Vinh, Firas Wehbe, Lisa B. Weissmann, Julie Wu, Elizabeth Wulff‐Burchfield, Zhuoer Xie, Albert C. Yeh, Peter Paul Yu, Alice Y. Zhou, Leyre Zubiri, Sanjay Mishra, Gary H. Lyman, Brian I. Rini, Jeremy L. Warner, Maheen Z. Abidi, Jared D. Acoba, Neeraj Agarwal, Syed A. Ahmad, Archana Ajmera, Jessica K. Altman, Anne H. Angevine, Nilo Azad, Michael Bär, Aditya Bardia, Jill S. Barnholtz‐Sloan, Briana Barrow, Babar Bashir, Rimma Belenkaya, Stephanie Berg, Eric Bernicker, Christine M. Bestvina, Rohit Bishnoi, Genevieve M. Boland, Mark Bonnen, Gabrielle Bouchard, Daniel W. Bowles, Fiona Busser, Angelo Cabal, Paolo F. Caimi, Theresa M. Carducci, Carla Casulo
The Lancet. 20201,805 CitationsOPEN ACCESS
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
Þorvarður R. Hálfdánarson, Kari G. Rabe, Joseph Rubin, Gloria M. Petersen
Annals of Oncology. 2008887 CitationsOPEN ACCESS
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
Yucai Wang, Shouhao Zhou, Fang Yang, Xinyue Qi, Xin Wang, Xiaoxiang Guan, Chan Shen, Narjust Duma, Jesus Vera Aguilera, Ashish V. Chintakuntlawar, Katharine A. Price, Julian R. Molina, Lance C. Pagliaro, Þorvarður R. Hálfdánarson, Axel Grothey, Svetomir N. Markovic, Grzegorz S. Nowakowski, Stephen M. Ansell, Michael Wang
JAMA Oncology. 2019860 CitationsOPEN ACCESS
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Manisha H. Shah, Whitney Goldner, Al B. Benson, Emily K. Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, J.K.C. Chan, Satya Das, Paxton V. Dickson, Paul T. Fanta, Thomas J. Giordano, Þorvarður R. Hálfdánarson, Daniel M. Halperin, Jin He, Anthony P. Heaney, Martin J. Heslin, Fouad Kandeel, Arash Kardan, Sajid Khan, Boris W. Kuvshinoff, Christopher H. Lieu, Kimberly D. Miller, Venu G. Pillarisetty, Diane Reidy‐Lagunes, Sarimar Agosto Salgado, Shagufta Shaheen, Heloisa P. Soares, Michael C. Soulen, Jonathan Strosberg, Craig Sussman, Nikolaos A. Trikalinos, N. Uboha, Namrata Vijayvergia, Terence Z. Wong, Beth Lynn, Cindy Hochstetler
Journal of the National Comprehensive Cancer Network. 2021612 Citations
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
Mark J. Truty, Michael L. Kendrick, David M. Nagorney, Rory L. Smoot, Sean P. Cleary, Rondell P. Graham, Ajit H. Goenka, Christopher L. Hallemeier, Michel G. Haddock, William S. Harmsen, Amit Mahipal, Robert R. McWilliams, Þorvarður R. Hálfdánarson, Axel Grothey
Annals of Surgery. 2019443 CitationsOPEN ACCESS

Related on ScholarIQ

Mayo Clinic
Institution
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Paper
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
Paper
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
Paper
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Paper
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
Paper
470M+ articles · free account